Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $5.8 million.

  • Dna X's Operating Expenses fell 1228.81% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 5351.8%. This contributed to the annual value of $43.6 million for FY2024, which is 13156.13% up from last year.
  • According to the latest figures from Q3 2025, Dna X's Operating Expenses is $5.8 million, which was down 1228.81% from $7.6 million recorded in Q2 2025.
  • Dna X's Operating Expenses' 5-year high stood at $21.9 million during Q4 2024, with a 5-year trough of $3.7 million in Q2 2023.
  • Over the past 5 years, Dna X's median Operating Expenses value was $7.1 million (recorded in 2022), while the average stood at $8.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 5806.35% in 2022, then skyrocketed by 24385.88% in 2024.
  • Dna X's Operating Expenses (Quarter) stood at $11.3 million in 2021, then tumbled by 55.66% to $5.0 million in 2022, then rose by 27.73% to $6.4 million in 2023, then soared by 243.86% to $21.9 million in 2024, then crashed by 73.56% to $5.8 million in 2025.
  • Its Operating Expenses was $5.8 million in Q3 2025, compared to $7.6 million in Q2 2025 and $7.7 million in Q1 2025.